Luis Miguel Ruilope Urioste-rekin lankidetzan egindako argitalpenak (9)

2016

  1. Serelaxin for the treatment of acute heart failure: A review with a focus on end-organ protection

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 2, Núm. 2, pp. 119-130

2006

  1. Blood pressure control in patients with chronic renal insufficiency in Spain: A cross-sectional study

    Journal of Hypertension, Vol. 24, Núm. 2, pp. 395-402

2002

  1. Pathophysiologic and therapeutic importance of tissue ACE: A consensus report

    Cardiovascular Drugs and Therapy, Vol. 16, Núm. 2, pp. 149-160

2001

  1. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease

    Journal of Hypertension, Vol. 19, Núm. 10, pp. 1871-1876

  2. The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data

    American Journal of Cardiology, Vol. 88, Núm. 9 SUPPL. 1, pp. 1-20

1995

  1. EFECTO DEL TRATAMIENTO ANTIHIPERTENSIVO SOBRE LA PROGRESION DE LA INSUFICIENCIA RENAL EN PACIENTES NO DIABETICOS (ESTUDIO ESPIRAL)

    Nefrologia, Vol. 15, Núm. 5, pp. 464-475

1993

  1. Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension?

    Journal of Hypertension, Vol. 11, pp. S192-S193

1992

  1. Abnormalities of renal function in essential hypertensives with increased circulating levels of insulin-like growth factor I

    Archives des Maladies du Coeur et des Vaisseaux, Vol. 85, Núm. 8, pp. 1189-1191

1991

  1. Insulin response to oral glucose in essential hypertensives with increased circulating levels of insulin growth factor I

    Journal of Hypertension, Vol. 9, pp. S174-S175